Palisade Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-22,233
| Closed | -$40K | – | 408 |
|
|
2022
Q3 | $40K | Buy |
22,233
+665
| +3% | +$1.2K | ﹤0.01% | 405 |
|
|
2022
Q2 | $122K | Hold |
21,568
| – | – | ﹤0.01% | 417 |
|
|
2022
Q1 | $260K | Buy |
21,568
+437
| +2% | +$5.27K | 0.01% | 402 |
|
|
2021
Q4 | $218K | Hold |
21,131
| – | – | ﹤0.01% | 415 |
|
|
2021
Q3 | $685K | Hold |
21,131
| – | – | 0.01% | 345 |
|
|
2021
Q2 | $905K | Hold |
21,131
| – | – | 0.02% | 334 |
|
|
2021
Q1 | $1.04M | Hold |
21,131
| – | – | 0.02% | 311 |
|
|
2020
Q4 | $742K | Hold |
21,131
| – | – | 0.02% | 319 |
|
|
2020
Q3 | $859K | Hold |
21,131
| – | – | 0.03% | 314 |
|
|
2020
Q2 | $951K | Hold |
21,131
| – | – | 0.03% | 306 |
|
|
2020
Q1 | $1.13M | Buy |
+21,131
| New | +$1.13M | 0.04% | 312 |
|